Why is Hikal falling/rising?

Dec 04 2025 12:40 AM IST
share
Share Via
On 03-Dec, Hikal Ltd’s stock price rose sharply by 8.45% to close at ₹243.75, marking a significant intraday high of ₹254.6. This rally comes despite the company’s ongoing fundamental challenges and a prolonged period of underperformance relative to market benchmarks.




Short-Term Price Movement and Market Activity


Hikal’s stock outperformed its sector by 13.02% on the day, trading within a wide range of ₹27.2, signalling heightened volatility and investor interest. The stock’s price currently sits above its 5-day, 20-day, and 50-day moving averages, suggesting short-term bullish momentum. However, it remains below the 100-day and 200-day moving averages, indicating that longer-term trends have yet to turn decisively positive.


Investor participation has notably increased, with delivery volumes on 02 Dec rising by 24.99% compared to the five-day average, reaching 83.52 lakh shares. This uptick in trading activity points to renewed buying interest, possibly driven by bargain hunting or speculative positioning amid the stock’s recent underperformance.



Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!



  • - Highest rated stock selection

  • - Multi-parameter screening cleared

  • - Large Cap quality pick



View Our Top 1% Pick →



Valuation and Fundamental Context


Despite the recent price rally, Hikal’s fundamentals remain under pressure. The stock has delivered a negative return of 45.10% over the past year, significantly underperforming the Sensex, which gained 5.27% in the same period. Over five years, the stock’s 40.09% gain also lags behind the Sensex’s robust 90.68% growth, underscoring persistent challenges.


The company’s profitability metrics paint a cautious picture. Return on Capital Employed (ROCE) stands at a modest 4.1%, while the average Return on Equity (ROE) is 8.00%, indicating limited efficiency in generating shareholder returns. Operating profits have declined at a compounded annual growth rate (CAGR) of -16.24% over five years, and profits have plunged by 86.2% in the past year alone.


Moreover, Hikal’s ability to service debt is constrained, with a Debt to EBITDA ratio of 2.51 times, reflecting elevated leverage. The company’s recent quarterly results were particularly weak, with a net loss of ₹34.90 crore and an earnings per share (EPS) decline of 320.54%, marking two consecutive quarters of negative performance. Operating profit to interest coverage ratio also remains low at 0.48 times, signalling financial strain.


Investor Sentiment and Market Dynamics


The current price appreciation appears to be driven more by market dynamics than by fundamental improvements. The stock is trading at a discount relative to its peers’ historical valuations, which may attract value-oriented investors seeking opportunities amid the broader sector’s recovery. The liquidity profile supports active trading, with the stock able to accommodate trade sizes of approximately ₹0.05 crore based on recent volumes.


While the weighted average price indicates that more volume has traded near the lower end of the day’s range, the overall upward movement and increased delivery volumes suggest that investors are gradually accumulating shares, possibly anticipating a turnaround or capitalising on short-term momentum.



Why settle for Hikal? SwitchER evaluates this Pharmaceuticals & Biotechnology Smallcap against peers, other sectors, and market caps to find you superior investment opportunities!



  • - Comprehensive evaluation done

  • - Superior opportunities identified

  • - Smart switching enabled



Discover Superior Stocks →



Long-Term Outlook and Risks


Despite today’s gains, Hikal’s long-term outlook remains clouded by weak earnings growth and profitability challenges. The company’s underperformance relative to the BSE500 index over one, three, and five-year periods highlights structural issues that have yet to be resolved. Promoter holdings remain significant, but this has not translated into improved operational results or investor confidence over recent quarters.


Investors should weigh the short-term price rally against the backdrop of deteriorating fundamentals and cautious financial metrics. The stock’s attractive valuation may offer some appeal, but the risks associated with declining profits, high leverage, and negative quarterly results warrant careful consideration.


Conclusion


In summary, Hikal’s 8.45% price rise on 03-Dec is primarily a reflection of increased investor participation and short-term technical strength rather than a turnaround in its fundamental performance. While the stock’s discount valuation and liquidity support trading interest, the company’s ongoing profitability challenges and weak financial ratios suggest that caution remains advisable for investors assessing its medium to long-term prospects.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News